Blink Therapeutics Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Blink Therapeutics Limited - overview
Established
2011
Location
-, Buckinghamshire, UK
Primary Industry
Biotechnology
About
Founded in 2011 and based in Marlow, UK, Blink Therapeutics Limited and operates as a biotechnology firm that develops therapeutic monoclonal antibodies for treating cancer.
Current Investors
BliNK Biomedical SAS
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Oncology/Cancer Treatment, Specialty Pharmaceuticals
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Blink Therapeutics Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Blink Therapeutics Limited, Valneva’s VivaScreen | - |
Displaying 1 - 1 of 1
Blink Therapeutics Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.